February Is National Cancer Prevention Month
February 22nd 2011There are about 12.7 million cancer cases globally every year, and this number is expected to increase to 26 million by 2030. The US has the 7th highest overall cancer rate in the world, according to age standardized estimates compiled by the Washington DC–based American Institute of Cancer Research (AICR) and the World Health Organization.a
ASTRO Publishes Guidelines for Palliative Radiotherapy for Bone Metastases
February 18th 2011The American Society for Radiation Oncology (ASTRO) has released guidelines for the use of radiation therapy in treating bone metastases; the guidelines are published in the International Journal of Radiation Oncology, Biology, Physics.
Survey of Oncology Nurses Finds US Cancer Centers Lack Formal Survivorship Programs
February 10th 2011While more than 12 million people in the US are cancer survivors, an online survey conducted by the Oncology Nursing Society (ONS) has found that only about one-quarter of oncology nurses surveyed had a formal survivorship program in place at their institutions.
Avastin in Combination With Chemo Associated With Increased Fatality
February 10th 2011A team of researchers at Stony Brook University School of Medicine in New York published a paper in JAMA last week showing that patients who receive Avastin (bevacizumab), in combination with chemotherapy are at increased risk of side effects that may lead to death
New Legislation Will Address Oncology Prescription Drug Shortages
February 9th 2011A new law, introduced by Senators Amy Klobuchar (D-Minnesota) and Bob Casey (D-Pennsylvania), will require prescription drug manufacturers to give the US Food and Drug Administration (FDA) early warning of anything that will likely result in a drug shortage.
FDA Denies Approval for Avodart for Prostate Cancer Prevention
February 1st 2011The GlaxoSmithKline (GSK) drug Avodart (dutasteride), already approved for treatment in men with enlarged prostate glands, has been rejected by the FDA for the additional indication of reducing the risk of prostate cancer.
Comparative Effectiveness Research and Health Reform
January 28th 2011A recent analysis in the Cancer Journal outlines the various effects of last year's landmark health care reform bill on cancer research. Some positive changes will be in the pipeline as will some potentially negative unanticipated consequences.
EHRs and Meaningful Use: The Ongoing Debate
January 27th 2011Recent data from the National Center for Health Statistics (NCHS) shows that an increasing number of primary care physicians have already adopted a basic EHR, but most physicians would need to further upgrade their EHR systems or their use of the systems in order to qualify for “meaningful use” incentive payments.
ASCO Issues New End-of-Life Policy Statement and Patient Guide
January 26th 2011ASCO’s QOPI analysis recently found that less than half of all cancer patients are enrolled in hospice care before their death and of those who are enrolled, one-third are not enrolled until the last week of their lives. In response to this and other findings, ASCO published a new policy and guidelines this week, intended to encourage physicians to initiate open dialogue about palliative care and treatment with patients as soon as they are identified as having incurable cancer.
Implementing EHRs in Community Oncology Practices
January 19th 2011To provide quality healthcare, communication is vital. Using an EHR, physicians can more easily communicate regarding current and past medical conditions with other providers in their practice, with referring or co-managing physicians, and with patients themselves.
NIH Study Predicts the Cost of Cancer Care will Increase 27% by 2020
January 13th 2011According to a recent analysis by researchers at the National Cancer Institute, in 2020, medical expenditures for cancer should reach at least $158 billion (in 2010 dollars). This represents an increase of 27 percent over 2010.